Neurocrine Biosciences
NBIX
#1288
Rank
NZ$24.36 B
Marketcap
$240.61
Share price
0.18%
Change (1 day)
17.91%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): NZ$1.05 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are NZ$2.24 Billion. In 2023 the company made an earning of NZ$0.63 Billion, an increase over its 2022 earnings that were of NZ$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$1.05 B65.74%
2023 NZ$0.63 B62.85%
2022 NZ$0.39 B73.74%
2021 NZ$0.22 B-8.82%
2020 NZ$0.24 B77.78%
2019 NZ$0.13 B49.83%
2018 NZ$92.88 M-142.57%
2017 -NZ$0.22 Billion-14.73%
2016 -NZ$0.26 Billion53.15%
2015 -NZ$0.17 Billion46.25%
2014 -NZ$0.12 Billion29.66%
2013 -NZ$88.11 Million-3530.8%
2012 NZ$2.56 M-95.73%
2011 NZ$60.16 M
2009 -NZ$84.58 Million-45.38%
2008 -NZ$0.16 Billion-58.87%
2007 -NZ$0.38 Billion87.3%
2006 -NZ$0.21 Billion351.97%
2005 -NZ$44.47 Million-52.09%
2004 -NZ$92.82 Million-10.98%
2003 -NZ$0.11 Billion
2001 -NZ$77.83 Million
1999 -NZ$35.1 Million108.32%
1998 -NZ$16.85 Million
1996 NZ$5.14 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$34.09 M-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.40 B 192.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$57.37 Million-104.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.00 B 1,445.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.76 B 995.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.31 B 957.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$13.31 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$74.07 Million-106.36%๐Ÿ‡บ๐Ÿ‡ธ USA